He has served as a clinical advisor and consultant to CapsoVision for nearly a decade. He succeeds Joanne C. Imperial, M.D., who has stepped down from the Board and will continue to support the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

"CapsoVision remains focused on advancing earlier, more accurate and more accessible detection of gastrointestinal disease for patients worldwide," said Co-Founder, President, CEO & Director Kang Wang ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Wang stated, "we now expect to submit our 510(k) application for CapsoCam Colon Gen 2 and its AI module in the third quarter of 2026." For the CapsoCam UGI pancreatic cancer initiative, he said, "we ...

CapsoVision develops and markets advanced capsule endoscopy systems. Its main products, CapsoCam Plus and the pipeline CapsoCam Colon, are swallowable cameras that capture images of the digestive ...

CapsoVision, Inc. closed its IPO, raising $27.5 million by selling 5.5 million shares at $5 each. CapsoVision, Inc. announced the successful closing of its initial public offering (IPO) on July 3, ...

SARATOGA, Calif., March 12, 2026 (GLOBE NEWSWIRE)-- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions ...

The average one-year price target for CapsoVision (NasdaqCM:CV) has been revised to $6.12 / share. This is an increase of 20.00% from the prior estimate of $5.10 dated November 7, 2025. The price ...

CapsoVision Inc. held its 2026 Annual Meeting of Stockholders on June 11, 2026, where shareholders voted on director elections and auditor ratification. The meeting outcomes confirm continuity in ...

Longtime Clinical Advisor and Capsule Endoscopy Pioneer Joins Board as Company Advances AI-Enabled Capsule Endoscopy Platform SARATOGA, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc.

CapsoVision (NASDAQ:CV) reported steady first-quarter revenue and said it continues to advance artificial intelligence and capsule endoscopy programs aimed at expanding the use of its gastrointestinal ...